奥美拉唑肠溶胶囊联合康复新液治疗 消化性溃疡的疗效分析
作者:
作者单位:

作者简介:

董淑萍,女,主治医师,主要从事内科的工作。

通讯作者:

中图分类号:

R 969.4;R 573.1

基金项目:


Therapeutic Effect of Omeprazole Enteric-coated Capsule Combined with Kangfuxin Liquid in the Treatment of Peptic Ulcer
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    摘 要目的:分析消化性溃疡患者采用奥美拉唑肠溶胶囊与康复新液联合治疗的临床效果。 方法:选取 2020 年 3 月 至 2022 年 7 月平顶山市妇幼保健院收治的 84 例消化性溃疡患者作为研究对象,随机分为对照组和观察组,各 42 例。对照 组单用奥美拉唑肠溶胶囊治疗,观察组采用奥美拉唑肠溶胶囊联合康复新液治疗。比较两组患者临床指标改善情况、临床 症状改善时间、临床疗效、不良反应发生情况。 结果:治疗后,两组患者各项临床指标均低于治疗前,且观察组低于对照组, 差异具有统计学意义(P < 0.05)。观察组患者各项临床症状改善时间均短于对照组,差异具有统计学意义(P < 0.05)。 观察组患者临床疗效率高于对照组,差异具有统计学意义(P < 0.05)。两组患者不良反应发生率比较,差异无统计学意义 (P > 0.05)。 结论:应用奥美拉唑肠溶胶囊联合康复新液治疗消化性溃疡患者,可以使其各项临床指标显著改善,缩短 症状缓解时间,提升临床疗效,且联合用药不会增加不良反应发生,具有安全性。

    Abstract:

    AbstractObjective To analyze the clinical effect of omeprazole enteric-coated capsule combined with Kangfuxin liquid in the treatment of patients with peptic ulcer. Methods A total of 84 patients with peptic ulcer admitted to Pingdingshan Maternal and Child Health Hospital from March 2020 to July 2022 were selected as the study objects and randomly divided into a control group and an observation group, with 42 cases in each group. The control group was treated with omeprazole enteric capsule alone, and the observation group was treated with omeprazole enteric-capsule combined with Kangfuxin solution. Clinical indicators, improvement time of clinical symptoms, clinical efficacy and occurrence of adverse reactions were compared between the two groups. Results After treatment, all clinical indexes in the two groups were lower than those before treatment, the clinical indexes in the observation group were lower than those in the control group, the differences were statistically significant (P < 0.05). The improvement time of clinical symptoms in the observation group were shorter than those in the control group, and the differences were statistically significant (P < 0.05). The clinical efficacy rate of the observation group was higher than that of the control group, and the difference was statistically significant (P < 0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P > 0.05). Conclusion The application of omeprazole enteric-coated capsule combined with Kangfuxin liquid in the treatment of patients with peptic ulcer can significantly improve various clinical indicators, shorten the time of symptom relief, and enhance clinical efficacy, and the combination of medication will not increase the occurrence of adverse reactions, and has safety.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2023-06-21
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-11-03
  • 出版日期:
重要通知

近期有不法分子冒充我刊名义给作者打电话或发邮件,编造各种理由要求添加微信或QQ、伪造复制我刊编辑部公章发放假冒录用通知书等等各种方式试图骗取作者钱财。我刊在此郑重声明:(1)杂志社与作者沟通方式为电话和邮件,在杂志社官方网站(http://www.szzxyjh.com)“联系我们”下拉菜单,或者网站最下端信息栏可以查询),绝对不会要求作者添加微信或QQ。此网站为我刊唯一官方网站,其他均为假冒网站。(2)我刊录用稿件仅收取合理版面制作费和审稿费,收款单位为“深圳市第二人民医院”对公账户,其他涉及私人账户者均为假冒。望广大作者提高警惕,谨防上当。谢谢配合!
《深圳中西医结合杂志》编辑部

关闭